ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
63,274.94
0.61%
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs Yen
153.055
0.01%
Brent Oil
82.765
0.00%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Oncternal Therapeutics Inc (ONCT)

  7. Oncternal Therapeutics Inc (ONCT) ニュース

ONCT

Oncternal Therapeutics (ONCT)

Oncternal Therapeutics Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:ONCT
日付受信時刻ニュースソース見出しコード企業名
2024/03/0906 : 42Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ONCTOncternal Therapeutics Inc
2024/03/0806 : 20Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ONCTOncternal Therapeutics Inc
2024/03/0806 : 10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONCTOncternal Therapeutics Inc
2024/02/2807 : 02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
2024/02/1608 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
2024/02/1608 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
2024/02/1608 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
2024/02/1608 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
2024/01/2406 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONCTOncternal Therapeutics Inc
2024/01/0606 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
2024/01/0606 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
2024/01/0606 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
2024/01/0606 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
2024/01/0606 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONCTOncternal Therapeutics Inc
2023/11/1006 : 30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ONCTOncternal Therapeutics Inc
2023/11/1006 : 15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONCTOncternal Therapeutics Inc
2023/10/0705 : 31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONCTOncternal Therapeutics Inc
2023/10/0506 : 01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
2023/10/0506 : 01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
2023/10/0505 : 59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
2023/10/0505 : 59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
2023/09/1505 : 01Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ONCTOncternal Therapeutics Inc
2023/08/1105 : 30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ONCTOncternal Therapeutics Inc
2023/08/1105 : 11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONCTOncternal Therapeutics Inc
2023/07/0607 : 59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
2023/07/0607 : 58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
2023/07/0607 : 58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
2023/07/0607 : 57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
2023/07/0105 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
2023/07/0105 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:ONCT

最近閲覧した銘柄

NYSE
BAC
Bank of America
NYSE
DIS
Walt Disney
NASDAQ
QQQ
Invesco QQQ Trust Series 1
USOTC
DTEGY
Deutsche Telekom (QX)
FX
USDJPY
US Dollar vs Yen
NASDAQ
AMZN
Amazon.com
NYSE
MCD
McDonalds
USOTC
ADDYY
Adidas (QX)
USOTC
BNPQY
BNP Paribas (QX)
NYSE
JPM
JP Morgan Chase
PM
XAUUSD
Gold vs US Dollar
COIN
SOLUSD
Solana
AMEX
XLE
Energy Select Sector SPDR
AMEX
XLF
Financial Select Sector
USOTC
RHHBY
Roche (QX)
CCOM
US30
US 30
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有